Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease† — Dan Joseph Stein (2009) | RDL Network
Patients who begin and continue an uninterrupted maintenance dosing regimen had a lower incidence of hospitalization and surgery than those who received an irregular or interrupted regimen prior to beginning an SM regimen.
Shahneen Sandhu, Victoria Atkinson, María González Cao, Theresa Medina, Ainara Soria Rivas, Alexander M. Menzies, Ivor Caro, Louise Roberts, Yuyao Song, Yibing Yan, Guo Yu, Cloris Xue, Georgina V. Long
María‐Victoria Mateos, Maria Gavriatopoulou, Thierry Façon, Holger W. Auner, Xavier Leleu, Roman Hájek, Meletios A Dimopoulos, Sosana Delimpasi, Maryana Simonova, Ivan Špıčka, Luděk Pour, Iryna Kriachok, Halyna Pylypenko, Vadim Doronin, Ganna Usenko, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Mamta Garg, Don A. Stevens, Hang Quach, Sundar Jagannath,
Е. V. Shlyakhto, S. V. Villevalde, Andrey Ezhov, S. A. Zenin, Н. А. Козиолова, О. Yu. Korennova, Т. N. Novikova, К. В. Протасов, G. Yu. Chumakova, Christine Teutsch, Shihai Lu, Professor Gregory Lip, Menno V. Huisman
Discussion(0)
No comments yet. Be the first to comment.